Coronary disease & ACS

Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention: Microvascular-Stratified Analysis of ORBITA

JACC Cardiovasc IntervPublished Secondary analysis of the ORBITA randomised trial

Primary result · Placebo-controlled change in treadmill exercise time, by MVRCFDResult — go to the resultDifference 48 seconds 95% CrI 6–92

Authors' conclusion

The placebo-controlled benefit of PCI was greater in patients with lower MVRCFD, but interactions with symptom-based endpoints were modest.

Study context

Population
Patients recruited for ORBITA (stable angina, severe single-vessel disease, optimal medical therapy)
Participants
131 patients
Comparison
Percutaneous coronary intervention (PCI) vs placebo, by microvascular resistance
  • PCIn = 66
  • Placebon = 65reference
Primary endpoint
Placebo-controlled change in treadmill exercise time by hyperemic MVRCFD
Follow-up
6-week follow-up
Methodological detailsplacebo-controlled, computational fluid dynamics
  • Placebo-controlled
  • Computational fluid dynamics

Primary result

As reported in the abstract

Placebo-controlled change in treadmill exercise time, by MVRCFD

Difference

48 seconds

95% CrI 6–92

PCIvs Placebo
difference 48 seconds (95% CrI 6–92)
Exercise time did not improve with high (80th centile) MVRCFD
16 seconds; 95% CrI: −29 to 61 seconds; Pr = 75.2%

Further findings

MVRCFD distribution

Median MVRCFD 1.38 mm Hg · min/mL
Q1-Q3: 0.89-2.09 mm Hg · min/mL

Baseline exercise time vs MVRCFD

Ordinal correlation coefficient
0.20 (95% CrI: 0.18-0.22)

Freedom from angina, angina frequency, stress echo scores, low MVRCFD

Complete freedom from angina, PCI benefit
Pr = 98.8%
Angina frequency improvement
Pr = 97.8%
Stress echocardiography scores improvement
Pr = 99.9%

Original publication

Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention: Microvascular-Stratified Analysis of ORBITA. JACC Cardiovasc Interv. Published 27 April 2026. doi:10.1016/j.jcin.2026.01.305

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.